Halozyme Therapeutics, Inc. (BIT:1HALO)
49.94
0.00 (0.00%)
At close: Aug 6, 2025, 5:30 PM CET
Halozyme Therapeutics Employees
Halozyme Therapeutics had 350 employees as of December 31, 2024. The number of employees decreased by 23 or -6.17% compared to the previous year.
Employees
350
Change (1Y)
-23
Growth (1Y)
-6.17%
Revenue / Employee
€2,867,541
Profits / Employee
€1,355,778
Market Cap
6.50B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 350 | -23 | -6.17% |
Dec 31, 2023 | 373 | -20 | -5.09% |
Dec 31, 2022 | 393 | 248 | 171.03% |
Dec 31, 2021 | 145 | 9 | 6.62% |
Dec 31, 2020 | 136 | 4 | 3.03% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UniCredit | 75,265 |
Intesa Sanpaolo | 94,736 |
Enel SpA | 60,359 |
Ferrari | 5,435 |
Assicurazioni Generali | 86,851 |
Eni S.p.A. | 32,492 |
Leonardo S.p.a. | 60,468 |
Poste Italiane | 125,097 |